These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36570624)

  • 1. A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration.
    Abidi M; Karrer E; Csaky K; Handa JT
    Ophthalmol Sci; 2022 Dec; 2(4):100213. PubMed ID: 36570624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
    Mettu PS; Allingham MJ; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ; Mettu PS; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection for Age-Related Macular Degeneration.
    Lin JB; Murakami Y; Miller JW; Vavvas DG
    Ophthalmol Sci; 2022 Dec; 2(4):100192. PubMed ID: 36570623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy.
    Cahill MT; Mruthyunjaya P; Bowes Rickman C; Toth CA
    Arch Ophthalmol; 2005 Jul; 123(7):935-8. PubMed ID: 16009834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Options Under Development for Nonneovascular Age-Related Macular Degeneration and Geographic Atrophy.
    Kim JB; Lad EM
    Drugs Aging; 2021 Jan; 38(1):17-27. PubMed ID: 33355716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects.
    Danis RP; Lavine JA; Domalpally A
    Clin Ophthalmol; 2015; 9():2159-74. PubMed ID: 26640366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy.
    Borchert GA; Shamsnajafabadi H; Ng BWJ; Xue K; De Silva SR; Downes SM; MacLaren RE; Cehajic-Kapetanovic J
    Front Neurosci; 2024; 18():1415575. PubMed ID: 39010943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.
    Cocce KJ; Stinnett SS; Luhmann UFO; Vajzovic L; Horne A; Schuman SG; Toth CA; Cousins SW; Lad EM
    Am J Ophthalmol; 2018 May; 189():127-138. PubMed ID: 29477964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 Inflammasome and Pathobiology in AMD.
    Celkova L; Doyle SL; Campbell M
    J Clin Med; 2015 Jan; 4(1):172-92. PubMed ID: 26237026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy.
    Khanani AM; Maturi RK; Bagheri N; Bakall B; Boyer DS; Couvillion SS; Dhoot DS; Holekamp NM; Jamal KN; Marcus DM; Pieramici D; Aziz AA; Patki KC; Bridges WZ; Barone SB
    Ophthalmol Sci; 2022 Jun; 2(2):100154. PubMed ID: 36249705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-luminance visual acuity and microperimetry in age-related macular degeneration.
    Wu Z; Ayton LN; Guymer RH; Luu CD
    Ophthalmology; 2014 Aug; 121(8):1612-9. PubMed ID: 24661863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperreflective Foci and Specks Are Associated with Delayed Rod-Mediated Dark Adaptation in Nonneovascular Age-Related Macular Degeneration.
    Echols BS; Clark ME; Swain TA; Chen L; Kar D; Zhang Y; Sloan KR; McGwin G; Singireddy R; Mays C; Kilpatrick D; Crosson JN; Owsley C; Curcio CA
    Ophthalmol Retina; 2020 Nov; 4(11):1059-1068. PubMed ID: 32389889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the management of dry age-related macular degeneration: A review.
    Bandello F; Sacconi R; Querques L; Corbelli E; Cicinelli MV; Querques G
    F1000Res; 2017; 6():245. PubMed ID: 28529701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for dry age-related macular degeneration: where we stand in 2024.
    Wheeler S; Mahmoudzadeh R; Randolph J
    Curr Opin Ophthalmol; 2024 Jun; ():. PubMed ID: 38869976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bruch's Membrane and the Choroid in Age-Related Macular Degeneration.
    Edwards M; Lutty GA
    Adv Exp Med Biol; 2021; 1256():89-119. PubMed ID: 33847999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.
    Balaratnasingam C; Messinger JD; Sloan KR; Yannuzzi LA; Freund KB; Curcio CA
    Ophthalmology; 2017 May; 124(5):644-656. PubMed ID: 28153442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration.
    Patel PN; Patel PA; Land MR; Bakerkhatib-Taha I; Ahmed H; Sheth V
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry.
    Leng T; Schwartz J; Nimke D; Gallivan M; Fevrier H; Rozario N; Schultz NM
    Ophthalmol Ther; 2023 Feb; 12(1):325-340. PubMed ID: 36369619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry Age-Related Macular Degeneration Pharmacology.
    Wright CB; Ambati J
    Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.